Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	275.86M
Revenue (ttm)	114.96M
Net Income (ttm)	20.48M
Shares Out	581.33M
EPS (ttm)	0.04
PE Ratio	13.46
Forward PE	14.03
Dividend	0.01 (2.67%)
Ex-Dividend Date	Sep 11, 2025

Volume	205,595
Average Volume	185,524
Open	0.6400
Previous Close	0.6375
Day's Range	0.6100 - 0.6500
52-Week Range	0.3050 - 0.8300
Beta	0.35
RSI	40.78
Earnings Date	Apr 8, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP